Evidence map›Paper›PMID 40354758›Full record

ArticleJournal of neurosurgery. Case lessons2025

Adult H3 K27-altered, H3.3 K27-mutant diffuse midline glioma affecting the conus medullaris: illustrative case.

Andrei Sincari, Saif Yousif, Thomas Robertson, Yi-Tung Tom Huang, Hamish Alexander

Abstract read
In one paragraph

Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrei SincariDepartment of Neurosurgery, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Saif YousifDepartment of Neurosurgery, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Thomas RobertsonDepartment of Pathology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.ORCID 0000-0001-6152-5511
Yi-Tung Tom HuangLumus Imaging, St. Vincent's Private Hospital Northside, Brisbane, Queensland, Australia.
Hamish AlexanderDepartment of Neurosurgery, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiffuse midline glioma (DMG) H3 K27-altered is a rare CNS tumor that predominantly affects midline structures in children. A relatively new subtype of glioma, it was first classified in 2016 and was further expanded in 2021 to include 4 molecular subtypes. While reported on in children, this is the first reported case of an H3.3 K27-mutant subtype of DMG affecting the conus medullaris in adults. OBSERVATIONS: The authors report the case of a 62-year-old man with gradual onset of bladder and lower-limb dysfunction over a 6-month period. Because of the patient's synchronous diagnosis of lymphoma, CSF sampling and positron emission tomography (PET) were initially utilized. Ultimately, an open biopsy was required to yield a diagnosis of H3 K27-altered DMG. After multiple disciplinary team discussions and discussions with the patient, radiotherapy was commenced. LESSONS: H3 K27-altered DMG affecting the conus medullaris is a very rare tumor that can present with gradual-onset lower-limb dysfunction and can be difficult to diagnose on traditional imaging alone. This case emphasized the continued importance of tissue sampling, with further research required on the utility of PET, CSF sampling, and the significance of molecular subtyping on treatment response and prognosis. https://thejns.org/doi/10.3171/CASE24879.

Indexed as

adultconus medullarisdiffuse midline gliomaH3.3 K27–mutatedH3 K27–alteredspinal cord

Identifiers

PMID40354758
PMCPMC12070302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.